Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMID 19538493)

Published in Am J Transplant on June 16, 2009

Authors

M G Ison1, J Hager, E Blumberg, J Burdick, K Carney, J Cutler, J M Dimaio, R Hasz, M J Kuehnert, E Ortiz-Rios, L Teperman, M Nalesnik

Author Affiliations

1: Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. mgison@northwestern.edu

Articles citing this

Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant (2013) 2.02

Infectious disease transmission during organ and tissue transplantation. Emerg Infect Dis (2012) 1.45

Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infection. Transplantation (2011) 1.42

PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation. Public Health Rep (2013) 1.17

Invasive fungal infections in solid organ transplant recipients. Future Microbiol (2012) 1.01

Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor. Am J Transplant (2013) 0.91

Posttransplant lymphoproliferative disease following liver transplantation. Curr Opin Organ Transplant (2011) 0.87

Respiratory Failure due to Possible Donor-Derived Sporothrix schenckii Infection in a Lung Transplant Recipient. Case Rep Infect Dis (2015) 0.83

Coding and traceability for cells, tissues and organs for transplantation. Cell Tissue Bank (2010) 0.82

Guidelines for the assessment and acceptance of potential brain-dead organ donors. Rev Bras Ter Intensiva (2016) 0.81

Expanded criteria donors. Clin Liver Dis (2014) 0.79

Preventable errors in organ transplantation: an emerging patient safety issue? Am J Transplant (2012) 0.79

Infections after orthotopic liver transplantation. J Clin Exp Hepatol (2014) 0.79

Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections. World J Transplant (2014) 0.78

Neoplastic disease after liver transplantation: Focus on de novo neoplasms. World J Gastroenterol (2015) 0.77

Endemic mycoses in immunocompromised hosts. Curr Infect Dis Rep (2013) 0.76

Urothelial carcinoma of donor origin in a kidney transplant patient. J Immunother Cancer (2016) 0.75

Implementation of a novel living-donor kidney transplant preoperative checklist within the electronic medical record: a pilot study. Patient Saf Surg (2015) 0.75

Hepatitis B transmission by cell and tissue allografts: how safe is safe enough? World J Gastroenterol (2014) 0.75

Articles by these authors

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation (2000) 5.41

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol (1992) 4.72

Liver from bone marrow in humans. Hepatology (2000) 4.10

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. N Engl J Med (1998) 3.76

Light control of Arabidopsis development entails coordinated regulation of genome expression and cellular pathways. Plant Cell (2001) 3.60

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med (2001) 3.33

Consensus statement on the live organ donor. JAMA (2000) 3.29

Colonization of skilled-care facility residents with antimicrobial-resistant pathogens. J Am Geriatr Soc (2001) 3.06

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68

Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med (1997) 2.40

Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA (1997) 2.11

Laparoscopic live donor nephrectomy: the recipient. Transplantation (2000) 2.11

Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04

Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant (2015) 2.03

Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis. Transpl Infect Dis (2015) 2.00

Vancomycin-resistant enterococci outside the health-care setting: prevalence, sources, and public health implications. Emerg Infect Dis (1997) 1.96

Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics (2001) 1.91

Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc (1991) 1.89

The point system for organ distribution. Transplant Proc (1989) 1.88

Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States. Am J Transplant (2011) 1.88

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation (2000) 1.85

Immunization practices of pediatricians and family physicians in the United States. Pediatrics (1994) 1.75

Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: an immediate source for thousands of new mouse models. Open Biol (2012) 1.65

Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol (1989) 1.65

Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant (2011) 1.59

A reexamination of the role of the RAD52 gene in spontaneous mitotic recombination. Curr Genet (1988) 1.58

Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation (1989) 1.58

De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant (2014) 1.57

Organ donation and utilization, 1995-2004: entering the collaborative era. Am J Transplant (2006) 1.57

Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients. Am J Transplant (2011) 1.54

Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant (1992) 1.54

Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke (1997) 1.54

Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology (2000) 1.54

Morphological monitoring of human small bowel allografts. Transplant Proc (1993) 1.52

Skills training for pregnancy and AIDS prevention in Anglo and Latino youth. J Adolesc Health (1998) 1.48

Nutritional support after liver transplantation: a randomized prospective study. JPEN J Parenter Enteral Nutr (1990) 1.43

Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT. Radiology (1996) 1.42

Statement from the National High Blood Pressure Education Program: prevalence of hypertension. Am J Hypertens (2000) 1.41

Thyroid releasing hormone test in schizophrenic patients with post-psychotic depression. Prog Neuropsychopharmacol Biol Psychiatry (1991) 1.39

Exposure data for cosmetic products: lipstick, body lotion, and face cream. Food Chem Toxicol (2005) 1.36

Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology (2000) 1.36

Intestinal parasites in a migrant farmworker population. Arch Intern Med (1986) 1.35

Cardiovascular risk factors among children after a 2 1/2-year intervention-The CATCH Study. Prev Med (1996) 1.31

Fibrolamellar hepatocellular carcinoma: imaging and pathologic findings in 31 recent cases. Radiology (1999) 1.29

Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1. Mol Psychiatry (2008) 1.27

Development and experience with an integrated system for transplantation telepathology. Hum Pathol (2001) 1.23

Primary cutaneous infection by Aspergillus ustus in a 62-year-old liver transplant recipient. J Am Acad Dermatol (1994) 1.23

Cancer in Cumbria: the Windscale connection. Lancet (1984) 1.22

Blood pressure and mortality among men with prior myocardial infarction. Multiple Risk Factor Intervention Trial Research Group. Circulation (1995) 1.21

Comparison of UW with other solutions for liver preservation in dogs. Clin Transplant (1989) 1.20

Obesity and hypertension: epidemiological and clinical issues. Eur Heart J (1987) 1.20

Rapid evaluation of risk of white particulate matter in blood components by a statewide survey of transfusion reactions. Transfusion (2004) 1.18

The Hypertension Prevention Trial: assessment of the quality of blood pressure measurements. Am J Epidemiol (1991) 1.18

In vitro effects of photodynamic therapy on Aspergillus fumigatus. J Antimicrob Chemother (2001) 1.18

Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet (1989) 1.17

Liver transplantation in cystic fibrosis. Lancet (1989) 1.15

Indication for linkage of the human OB gene region with extreme obesity. Diabetes (1996) 1.10

INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results. Therapie (1995) 1.10

Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians. Diabetes (1997) 1.09

Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report. Am J Transplant (2012) 1.08

Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc (1993) 1.08

Prevalence of the use of unconventional remedies for arthritis in a metropolitan community. Arthritis Rheum (1989) 1.07

Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression. Transplant Proc (1991) 1.06

Candidate gene approach of familial morbid obesity: linkage analysis of the glucocorticoid receptor gene. Int J Obes Relat Metab Disord (1996) 1.05

Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. J Infect Dis (1999) 1.05

Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant (2010) 1.05

FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05

Transplants in Foreign Countries Among Patients Removed from the US Transplant Waiting List. Am J Transplant (2008) 1.05

A new percutaneous technique for establishing venous bypass access in orthotopic liver transplantation. J Cardiothorac Vasc Anesth (1994) 1.04

Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc (1994) 1.03

The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study. Am J Pathol (1991) 1.02

Genetics of NIDDM in France: studies with 19 candidate genes in affected sib pairs. Diabetes (1997) 1.02

Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J Pharmacol Exp Ther (1980) 1.02

Severe contractures of the proximal interphalangeal joint in Dupuytren's disease: results of a prospective trial of operative correction and dynamic extension splinting. J Hand Surg Am (1992) 1.01

Thalidomide revisited. Lancet (1994) 1.00

Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. Transplant Proc (1996) 0.99

F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy. Trans R Soc Trop Med Hyg (1999) 0.98

Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts. Transplantation (1995) 0.98

Use of factor analysis to consolidate multiple outcome measures in chronic obstructive pulmonary disease. J Clin Epidemiol (1991) 0.97

Computer-tomographical appearances of the Chiari malformations of the posterior fossa. Z Kinderchir (1986) 0.96

Time trends in the association of a rural or urban background with physician location. J Med Educ (1979) 0.96

Current practices and evaluation of screening solid organ donors for West Nile virus. Transpl Infect Dis (2012) 0.96

Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation (1999) 0.96

Effects of eye size on adults' aesthetic ratings of faces and 5-month-olds' looking times. Perception (1999) 0.95

The successful use of older donors for liver transplantation. JAMA (1989) 0.95

Exposure data for cosmetic products: facial cleanser, hair conditioner, and eye shadow. Food Chem Toxicol (2007) 0.95

High resolution respirometry of permeabilized skeletal muscle fibers in the diagnosis of neuromuscular disorders. Mol Cell Biochem (1997) 0.94

Pregnancy, STDS, and AIDS prevention: evaluation of New Image Teen Theatre. AIDS Educ Prev (1991) 0.93

Metabolic and morphologic studies in intraportal-islet-transplanted rats. Diabetes (1976) 0.92

Impact of fat reduction on micronutrient density of children's diets: the CATCH Study. Prev Med (1996) 0.92

Haplotypes in the gene encoding protein kinase c-beta (PRKCB1) on chromosome 16 are associated with autism. Mol Psychiatry (2005) 0.91

The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats. Transplantation (1992) 0.91

Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. Am J Cardiol (1989) 0.91